• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Composition of the Stabilizer and Conditions of Lyophilization for Preserving Infectious Activity of Influenza Virus

tetano

Editor, Senior Moderator
Bull Exp Biol Med. 2018 May 24. doi: 10.1007/s10517-018-4097-7. [Epub ahead of print]
[h=1]Composition of the Stabilizer and Conditions of Lyophilization for Preserving Infectious Activity of Influenza Virus.[/h] Dubrovina IA[SUP]1[/SUP], Kiseleva IV[SUP]2[/SUP], Kireeva EV[SUP]1[/SUP], Rudenko LG[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] For stabilization of vaccine preparations, they are lyophilized. The composition of the protective medium is an important parameter affecting the quality of the vaccine after drying. In view of the risk of spreading prion diseases, the use of media containing animal proteins is not recommended. In this study, protective media containing no animal proteins and lyophilization regimen were determined. The optimum lyophilization regimen consisted of three stages: freezing at -70?C, main stage at -35?C, and drying at 24?C. Protective medium containing 4% trehalose or protective medium with 10% sucrose and 5% soy peptone ensured highest stability of the lyophilized vaccine preparation in temperature range of 4-24?C. This can help to overcome possible break in the cold chain, which is important during transporting or storage of vaccine preparations.


[h=4]KEYWORDS:[/h] influenza viruses; live influenza vaccine; lyophilization; stabilizers

PMID: 29796807 DOI: 10.1007/s10517-018-4097-7
 
Back
Top Bottom